IL323883A - Crystalline lysine acetyltransferase 6a (kat6a) inhibitor and uses thereof - Google Patents
Crystalline lysine acetyltransferase 6a (kat6a) inhibitor and uses thereofInfo
- Publication number
- IL323883A IL323883A IL323883A IL32388325A IL323883A IL 323883 A IL323883 A IL 323883A IL 323883 A IL323883 A IL 323883A IL 32388325 A IL32388325 A IL 32388325A IL 323883 A IL323883 A IL 323883A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- xrpd
- crystalline form
- pattern
- radiation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2023090649 | 2023-04-25 | ||
| PCT/CN2024/089494 WO2024222725A1 (en) | 2023-04-25 | 2024-04-24 | Crystalline lysine acetyltransferase 6a (kat6a) inhibitor and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL323883A true IL323883A (en) | 2025-12-01 |
Family
ID=93255616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL323883A IL323883A (en) | 2023-04-25 | 2025-10-12 | Crystalline lysine acetyltransferase 6a (kat6a) inhibitor and uses thereof |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4702019A1 (de) |
| KR (1) | KR20260016479A (de) |
| CN (1) | CN121358730A (de) |
| AU (1) | AU2024262206A1 (de) |
| IL (1) | IL323883A (de) |
| MX (1) | MX2025012350A (de) |
| WO (1) | WO2024222725A1 (de) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201810092D0 (en) * | 2018-06-20 | 2018-08-08 | Ctxt Pty Ltd | Compounds |
| CN114072394A (zh) * | 2019-04-25 | 2022-02-18 | 拜耳股份公司 | 用于治疗癌症的酰基磺酰胺 |
| PH12021553107A1 (en) * | 2019-06-18 | 2022-08-01 | Ctxt Pty Ltd | Benzisoxazole sulfonamide derivatives |
| AU2020295006B2 (en) * | 2019-06-19 | 2023-11-09 | Ctxt Pty Ltd | Cycloalkyl and heterocycloalkyl benzisoxazole sulfonamide derivatives |
| WO2023088233A1 (en) * | 2021-11-16 | 2023-05-25 | Insilico Medicine Ip Limited | Lysine acetyltransferase 6a (kat6a) inhibitors and uses thereof |
-
2024
- 2024-04-24 EP EP24796103.0A patent/EP4702019A1/de active Pending
- 2024-04-24 KR KR1020257038910A patent/KR20260016479A/ko active Pending
- 2024-04-24 AU AU2024262206A patent/AU2024262206A1/en active Pending
- 2024-04-24 CN CN202480041844.2A patent/CN121358730A/zh active Pending
- 2024-04-24 WO PCT/CN2024/089494 patent/WO2024222725A1/en not_active Ceased
-
2025
- 2025-10-12 IL IL323883A patent/IL323883A/en unknown
- 2025-10-16 MX MX2025012350A patent/MX2025012350A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4702019A1 (de) | 2026-03-04 |
| AU2024262206A1 (en) | 2025-12-04 |
| WO2024222725A1 (en) | 2024-10-31 |
| CN121358730A (zh) | 2026-01-16 |
| KR20260016479A (ko) | 2026-02-03 |
| MX2025012350A (es) | 2025-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112888690B (zh) | 取代的吡咯并嘧啶类cdk抑制剂的盐及其结晶和用途 | |
| EP4455147A1 (de) | Polymorph eines kras-inhibitors, herstellungsverfahren dafür und verwendung davon | |
| WO2017219948A1 (en) | Crystalline forms of triazolopyrimidine compound | |
| WO2020147838A1 (zh) | 一种egfr抑制剂的盐、晶型及其制备方法 | |
| CN118791505A (zh) | 一种含肟结构的杂环化合物及其制备方法与用途 | |
| WO2006074293A2 (en) | Bicyclic dihydropyrimidines as eg5 inhibitors | |
| CN115677730B (zh) | 8-氧-3-氮杂二环[3.2.1]辛烷类化合物或其盐及其制备方法和用途 | |
| CA3244743A1 (en) | SALT OF A SIX-LINK AMINO-SUBSTITUTE NITRIC HETEROCYCLIC COMPOUND, CRYSTALLINE FORM THEREIN, CORRESPONDING PREPARATION PROCESS AND ASSOCIATED USE | |
| EP3418277B1 (de) | Substituierte amino-sechsgliedrige stickstoffheterocyclische ringverbindung sowie deren herstellung und verwendung | |
| TW200539868A (en) | Novel 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid amides | |
| EP4043457A1 (de) | Aromatische heterocyclische verbindung mit einer tricyclischen struktur, herstellungsverfahren dafür und anwendung davon | |
| CN118076614A (zh) | 一种egfr抑制剂的多晶型 | |
| WO2024222725A1 (en) | Crystalline lysine acetyltransferase 6a (kat6a) inhibitor and uses thereof | |
| CN121443610A (zh) | 一种plk1激酶抑制剂的盐型、晶型及其制备方法和应用 | |
| CN110684016A (zh) | 一种含氟的azd9291衍生物及其制备方法和应用 | |
| EP3941472B1 (de) | Crystalline and amorphous forms of-(5-((4-ethylpiperazin-1-yl)methyl)pyridine-2-yl)-5-fluoro-4-(3-isopropyl-2-methyl-2 <ns1:i>h</ns1:i>?-indazol-5-yl)pyrimidin-2-amine and its salts, and preparation methods and therapeutic uses thereof | |
| CN113966330B (zh) | Plk4抑制剂的晶型s4 | |
| CN113717165A (zh) | 新型三环芳香杂环化合物，及其制备方法、药物组合物和应用 | |
| CN112125910A (zh) | 一种阿伐普替尼晶型及其制备方法 | |
| AU2015392050B2 (en) | Fumarate of pyridylamine compound and crystals thereof | |
| EP4631937A1 (de) | Kristalline form oder amorphe form einer oxoisoindol-5-formamidverbindung oder salz und solvat davon | |
| US11932641B1 (en) | Pyrido[4′,3′:4,5]pyrrolo[3,2-b][1,7]naphthyridine compounds as CK2 inhibitors | |
| CN116102545B (zh) | 一种二芳基脲类PI3K/mTOR/HDAC多靶点抑制剂及其药物组合物和应用 | |
| CN115916759B (zh) | 取代喹唑啉类化合物、其制备方法、药物组合及应用 | |
| CN109535149B (zh) | 甲磺酸替扎尼定化合物及其制备方法和用途 |